Skip to main content
Professional Technical IVT

BRONJ

Pronunciation: BRONJ

Also written as: BRONJ — bisphosphonate-related osteonecrosis of the jaw

Acronym for bisphosphonate-related osteonecrosis of the jaw, a serious complication associated with bisphosphonate therapy.

Full Definition

BRONJ (bisphosphonate-related osteonecrosis of the jaw) is a well-recognized adverse effect of bisphosphonate therapy characterized by exposed, necrotic bone in the oral cavity that persists for more than eight weeks in patients with no history of radiation therapy to the jaw. This condition predominantly affects the mandible and maxilla and is associated with dental extractions, dental implant placement, or other invasive oral procedures. The pathophysiology involves impaired bone remodeling and healing due to bisphosphonate-induced suppression of osteoclast activity.

Usage

Usage note: Now often referred to as MRONJ (medication-related osteonecrosis of the jaw) to include other medications beyond bisphosphonates.

In Context

  • "The patient's history of alendronate therapy raised concerns about potential BRONJ development following the planned extraction." — Pre-surgical risk assessment
  • "Conservative management of BRONJ included antimicrobial mouth rinses and oral antibiotics." — Treatment protocol documentation

Also known as

bisphosphonate osteonecrosis medication-related osteonecrosis of the jaw

Don't confuse with

MRONJ ONJ osteoradionecrosis

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON